Crinetics Pharmaceuticals EPS Diluted from Extraordinaries (Quarterly) Analysis

Crinetics Pharmaceuticals, Inc. (CRNX)

43.84 +0.40 (+0.92%) USD | NASDAQ | Feb 23, 16:00

43.84 0.00 (0.00%) After-Hours: 19:59

View EPS Diluted from Extraordinaries (Quarterly) for CRNX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Diluted from Extraordinaries (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Diluted from Extraordinaries (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Diluted from Extraordinaries (Quarterly) Benchmarks

Start Trial

Madrigal Pharmaceuticals, Inc.	--
GT Biopharma, Inc.	--
Axsome Therapeutics, Inc.	--
Sutro Biopharma, Inc.	--
Gossamer Bio, Inc.	--